Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03335813 · ClinicalTrials.gov registry record · NA
Endoesophageal Brachytherapy for Patients With Esophageal Cancer
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03335813: Completed NA study, sponsored by Case Comprehensive Cancer Center.
NCT03335813 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03335813, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Depending upon the cancer stage, esophageal cancer can be treated with surgery, chemotherapy, radiation therapy, or a combination of these modalities. Sometimes in addition to external radiation therapy or instead of external radiation therapy, select patients with esophageal cancer may benefit from localized radiation to the tumor, called esophageal brachytherapy. There are many different radiation techniques and delivery approaches for this type of specialized radiation therapy, and the purpose of this document is to provide a written summary of an innovative delivery method.
Primary Outcome
Percent of prescription dose received by 90% of PTV (planning target volume)
Interventions
- DEVICE Endoesophageal Brachytherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-03-06 |
| Est. Completion | 2020-12-08 |
| Phase | NA |
What the finished NCT03335813 record still lists
NCT03335813 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Endoesophageal Brachytherapy is the first listed.
NCT03335813 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03335813 about?
NCT03335813 is a clinical study titled "Endoesophageal Brachytherapy for Patients With Esophageal Cancer". Depending upon the cancer stage, esophageal cancer can be treated with surgery, chemotherapy, radiation therapy, or a combination of these modalities. Sometimes in addition to external radiation therapy or instead of external radiation therapy, select patients with esophageal cancer may benefit from...
What is the current status of trial NCT03335813?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2018-03-06. Estimated completion is 2020-12-08.
What interventions are being tested in trial NCT03335813?
The interventions under investigation include: Endoesophageal Brachytherapy (DEVICE).
Who is sponsoring clinical trial NCT03335813?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03335813's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI